Biomarin Pharmaceutical Inc. - Registered Shares

NASDAQ:BMRN   3:59:56 PM EDT
86.20
+1.96 (+2.33%)
Products

Biomarin Receives FDA Approval For Voxzogo For Injection

Published: 11/19/2021 19:11 GMT
Biomarin Pharmaceutical Inc. - Registered Shares (BMRN) - Biomarin Receives FDA Approval for Voxzogo™ (vosoritide) for Injection, Indicated to Increase Linear Growth in Children With Achondroplasia Aged 5 and Up With Open Growth Plates.
Biomarin Pharmaceutical Inc - Voxzogo is Expected to Be Available in United States by Mid- to Late-december.